Authors
Akbarian, SchahramWeng, Zhiping
Mattei, Eugenio
Purcaro, Michael
Tsuji, Junko
Senthil, Geetha
Lehner, Thomas
Sklar, Pamela
Sestan, Nenad
PsychENCODE Consortium
UMass Chan Affiliations
Department of Biochemistry and Molecular PharmacologyProgram in Bioinformatics and Integrative Biology
Document Type
Journal ArticlePublication Date
2015-11-25Keywords
BiomarkersDiseases of the nervous system
Epigenomics
Transcriptomics
Computational Biology
Computational Neuroscience
Genetics
Genomics
Mental Disorders
Molecular and Cellular Neuroscience
Nervous System Diseases
Metadata
Show full item recordAbstract
Recent research on disparate psychiatric disorders has implicated rare variants in genes involved in global gene regulation and chromatin modification, as well as many common variants located primarily in regulatory regions of the genome. Understanding precisely how these variants contribute to disease will require a deeper appreciation for the mechanisms of gene regulation in the developing and adult human brain. The PsychENCODE project aims to produce a public resource of multidimensional genomic data using tissue- and cell type–specific samples from approximately 1,000 phenotypically well-characterized, high-quality healthy and disease-affected human post-mortem brains, as well as functionally characterize disease-associated regulatory elements and variants in model systems. We are beginning with a focus on autism spectrum disorder, bipolar disorder and schizophrenia, and expect that this knowledge will apply to a wide variety of psychiatric disorders. This paper outlines the motivation and design of PsychENCODE.Source
Nat Neurosci. 2015 Nov 25;18(12):1707-12. doi: 10.1038/nn.4156. Link to article on publisher's siteDOI
10.1038/nn.4156Permanent Link to this Item
http://hdl.handle.net/20.500.14038/39859PubMed ID
26605881Notes
Full author list omitted for brevity. For the full list of authors, see article.
Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1038/nn.4156